BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8813131)

  • 1. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
    Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organization of the human KAI1 metastasis-suppressor gene.
    Dong JT; Isaacs WB; Barrett JC; Isaacs JT
    Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene.
    Gao AC; Lou W; Dong JT; Barrett JC; Danielpour D; Isaacs JT
    Prostate; 2003 Dec; 57(4):256-60. PubMed ID: 14601021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A; Lamb PW; Barrett JC
    Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
    Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.
    Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J
    Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
    Gao AC; Lou W; Dong JT; Isaacs JT
    Cancer Res; 1997 Mar; 57(5):846-9. PubMed ID: 9041184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-met proto-oncogene expression in benign and malignant human prostate tissues.
    Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
    J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.